Unibest

UB310

TargetsJAK1; JAK2
IndicationsPrurigo nodularis
ClinicalCN - II
TherapeuticsImmunology & Inflammation; Dermatology
ModalitiesSmall Molecule

How can we help you?

Receive insights into the latest events and regulatory updates

Sent directly to your email

Get industry insights and Unibest news here

Contact Us →